Ajanta Pharma Ltd’s shares were up 5 per cent at Rs 2,160 on the Bombay Stock Exchange in Friday’s intra-day trade after the company said its board would meet on December 28 to consider a share buyback plan.
“The meeting of the board of directors of the Company is scheduled on Tuesday, December 28, 2021, to consider a proposal for buy-back of equity shares including matters related /incidental to it,” Ajanta Pharma said.
- Religare Enterprises Shares Slumped 6% on Demerger Plan
- Natco Pharma Gets CDSCO Nod; Shares Rally 12.5%
- Lodha Developers Buys Solidrise for Rs 300 Cr; Shares Jump 1.5%
- Stocks in Focus: Garden Reach Shipbuilder, Hindustan Copper, and Others
- Stocks Under F&O Ban: Sammaan Capital, and Others
Buyback is a corporate action in which a company buys back its shares from the existing shareholders, usually higher than the market price. When it buys back shares, the number of outstanding shares in the market reduces.
Stock Covered in the news
Live
